Document is current
Any future updates will be listed below
-
Authors
Zhang, Mengli
Hyle, Judith
Chen, Xiaowen
Xin, Ye
Jin, Yingcai
Zhang, Jianxiang
Yang, Xue
Chen, Xinfeng
Wright, Shaela
Liu, Zhenling
Rosikiewicz, Wojciech
Xu, Beisi
He, Liusheng
Liu, Hong
Ping, Nana
Wu, Depei
Wen, Feiqiu
Li, Chunliang http://orcid.org/0000-0002-5938-5510
Xu, Peng
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2022YFC2502700, 2022YFC25022701, 2022YFC2502702)
National Natural Science Foundation of China (82170119)
American Lebanese Syrian Associated Charities
Science and Technology Support Program of Jiangsu Province (BK20210714, JSSCBS20210692)
Suzhou Gusu Medical Youth Talent (ZXL2022443)
- License Information
-
More Information
Article History
Received: 12 August 2023
Accepted: 20 December 2023
First Online: 12 January 2024
Declarations
:
: All the primary cells of five AML patients and three healthy donors were from Hematologic Biobank, National Clinical Research Center for Hematologic Diseases, Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform, and The First Affiliated Hospital of Soochow University. The informed consent forms were approved by the Ethics Committee of Soochow University and The First Affiliated Hospital of Soochow University (ID: 2017169–3, Suzhou, China), in accordance with the Declaration of Helsinki.
: Wenjing She was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
: Dr. Chunliang Li is an editorial board member for <i>Genome Biology</i>. The other authors declare that they have no competing interests.
